永安药业

002365 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

4.0B ($580.8M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

839.0M

Net Income

59.7M

Gross Margin

N/A

Op. Margin

8.7%

Net Margin

7.1%

ROE

2.9%

ROA

2.6%

D/E

0.13

Dividend Yield

N/A

EPS

0.21

Current Ratio

4.83

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmaceutical Co., Ltd. was founded in 2001 and is based in Qianjiang, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 永安药业

Ticker	002365
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业